Medical Cannabis and Conditions Affecting Assigned Female At Birth and Intersex People (for Nurses)
-
Overview
Designed for nurses, this course delves into a range of conditions that are uniquely prevalent among people assigned female at birth and intersex individuals with female reproductive organs. These conditions often go underrecognised and can profoundly affect health and quality of life. Conventional treatments sometimes fail to fully address these issues and can carry significant risks.
With medical cannabis emerging as a promising alternative, this course offers evidence-based insights into its potential for managing symptoms of:
- Endometriosis
- Dysmenorrhoea
- Polycystic Ovary Syndrome (PCOS)
- Premenstrual Dysphoric Disorder (PMDD)
- Postpartum Depression (PPD)
- Breast, ovarian, and uterine cancers
- Perimenopause and menopause
Additionally, it covers critical pregnancy-related contraindications for medical cannabis.
Healthcare professionals will gain crucial knowledge and skills to expand their therapeutic toolkit, integrating both traditional and cannabis-based approaches to enhance patient outcomes.
This is an opportunity to stay at the forefront of medical advancements and provide innovative care options for your patients.
Preview this course by watching the video above.
Estimated Duration: 5.5 hours
Access Duration: 12 months from date of purchase
Learning Outcomes
Upon completion of this course, you’ll be able to:
- Assess medical cannabis’ therapeutic potential for treating symptoms of dysmenorrhoea, endometriosis, PCOS, PMDD, PPD, menopause, and breast, ovarian and uterine cancers considering its pharmacological interaction with the condition’s pathophysiology and efficacy, and drawbacks of current recommended treatments
- Identify characteristics of suitable medical cannabis strains, compounds, product types and administration methods for treating symptoms of the particular condition affecting IAFABP
- Identify and explain pregnancy-related contraindications for using medical cannabis
Overview
Designed for nurses, this course delves into a range of conditions that are uniquely prevalent among people assigned female at birth and intersex individuals with female reproductive organs. These conditions often go underrecognised and can profoundly affect health and quality of life. Conventional treatments sometimes fail to fully address these issues and can carry significant risks.
With medical cannabis emerging as a promising alternative, this course offers evidence-based insights into its potential for managing symptoms of:
- Endometriosis
- Dysmenorrhoea
- Polycystic Ovary Syndrome (PCOS)
- Premenstrual Dysphoric Disorder (PMDD)
- Postpartum Depression (PPD)
- Breast, ovarian, and uterine cancers
- Perimenopause and menopause
Additionally, it covers critical pregnancy-related contraindications for medical cannabis.
Healthcare professionals will gain crucial knowledge and skills to expand their therapeutic toolkit, integrating both traditional and cannabis-based approaches to enhance patient outcomes.
This is an opportunity to stay at the forefront of medical advancements and provide innovative care options for your patients.
Preview this course by watching the video above.
Estimated Duration: 5.5 hours
Access Duration: 12 months from date of purchase
Learning Outcomes
Upon completion of this course, you’ll be able to:
- Assess medical cannabis’ therapeutic potential for treating symptoms of dysmenorrhoea, endometriosis, PCOS, PMDD, PPD, menopause, and breast, ovarian and uterine cancers considering its pharmacological interaction with the condition’s pathophysiology and efficacy, and drawbacks of current recommended treatments
- Identify characteristics of suitable medical cannabis strains, compounds, product types and administration methods for treating symptoms of the particular condition affecting IAFABP
- Identify and explain pregnancy-related contraindications for using medical cannabis